Febrile neutropenia, related hospitalizations and chemotherapy delivery in breast cancer patients younger than 65 years receiving pegfilgrastim primary prophylaxis vs current practice neutropenia management
Publication
, Conference
Schwenkqlenks, M; Von Minckwitz, G; Lyman, G; Lopez-Pousa, A; Bacon, P; Lawrinson, S; Aapro, M
Published in: European Journal of Cancer Supplements
April 2008
Duke Scholars
Published In
European Journal of Cancer Supplements
DOI
ISSN
1359-6349
Publication Date
April 2008
Volume
6
Issue
7
Start / End Page
68 / 68
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Schwenkqlenks, M., Von Minckwitz, G., Lyman, G., Lopez-Pousa, A., Bacon, P., Lawrinson, S., & Aapro, M. (2008). Febrile neutropenia, related hospitalizations and chemotherapy delivery in breast cancer patients younger than 65 years receiving pegfilgrastim primary prophylaxis vs current practice neutropenia management. In European Journal of Cancer Supplements (Vol. 6, pp. 68–68). Elsevier BV. https://doi.org/10.1016/s1359-6349(08)70378-1
Schwenkqlenks, M., G. Von Minckwitz, G. Lyman, A. Lopez-Pousa, P. Bacon, S. Lawrinson, and M. Aapro. “Febrile neutropenia, related hospitalizations and chemotherapy delivery in breast cancer patients younger than 65 years receiving pegfilgrastim primary prophylaxis vs current practice neutropenia management.” In European Journal of Cancer Supplements, 6:68–68. Elsevier BV, 2008. https://doi.org/10.1016/s1359-6349(08)70378-1.
Schwenkqlenks M, Von Minckwitz G, Lyman G, Lopez-Pousa A, Bacon P, Lawrinson S, et al. Febrile neutropenia, related hospitalizations and chemotherapy delivery in breast cancer patients younger than 65 years receiving pegfilgrastim primary prophylaxis vs current practice neutropenia management. In: European Journal of Cancer Supplements. Elsevier BV; 2008. p. 68–68.
Schwenkqlenks, M., et al. “Febrile neutropenia, related hospitalizations and chemotherapy delivery in breast cancer patients younger than 65 years receiving pegfilgrastim primary prophylaxis vs current practice neutropenia management.” European Journal of Cancer Supplements, vol. 6, no. 7, Elsevier BV, 2008, pp. 68–68. Crossref, doi:10.1016/s1359-6349(08)70378-1.
Schwenkqlenks M, Von Minckwitz G, Lyman G, Lopez-Pousa A, Bacon P, Lawrinson S, Aapro M. Febrile neutropenia, related hospitalizations and chemotherapy delivery in breast cancer patients younger than 65 years receiving pegfilgrastim primary prophylaxis vs current practice neutropenia management. European Journal of Cancer Supplements. Elsevier BV; 2008. p. 68–68.
Published In
European Journal of Cancer Supplements
DOI
ISSN
1359-6349
Publication Date
April 2008
Volume
6
Issue
7
Start / End Page
68 / 68
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis